149 related articles for article (PubMed ID: 10432945)
1. [New developments in therapy of non-Hodgkin lymphomas with monoclonal antibodies].
Buske C; Feuring-Buske M; Unterhalt M; Hiddemann W
Dtsch Med Wochenschr; 1999 Jul; 124(27):842-7. PubMed ID: 10432945
[No Abstract] [Full Text] [Related]
2. Monoclonal antibody therapy for indolent lymphomas.
Grossbard ML; Nadler LM
Semin Oncol; 1993 Oct; 20(5 Suppl 5):118-35. PubMed ID: 8211202
[No Abstract] [Full Text] [Related]
3. [Radioimmunoconjugates: therapy of non-Hodgkin lymphomas and colorectal carcinomas].
Griesinger F; Trümper L; Becker W
Internist (Berl); 2001 Jun; 42(6):860-4, 866-73. PubMed ID: 11449633
[No Abstract] [Full Text] [Related]
4. Development of targeted therapies for B-cell non-Hodgkin lymphoma and multiple myeloma.
Hernandez-Ilizaliturri FJ; Gowda A; Czuczman MS
Clin Adv Hematol Oncol; 2004 Sep; 2(9):606-18. PubMed ID: 16163245
[TBL] [Abstract][Full Text] [Related]
5. [Monoclonal antibody therapy for malignant lymphoma].
Buske C; Dreyling M; Unterhalt M; Hiddemann W
Med Klin (Munich); 2005 Jan; 100(1):14-24. PubMed ID: 15654538
[TBL] [Abstract][Full Text] [Related]
6. Clinical trials referral resource. Current clinical trials of the anti-CD20 monoclonal antibody rituximab.
Davis T; Gore-Langton RE; Cheson BD
Oncology (Williston Park); 2000 Oct; 14(10):1437, 1440-3. PubMed ID: 11098509
[No Abstract] [Full Text] [Related]
7. Prospects for the management of non-Hodgkin's lymphomas with monoclonal antibodies and immunoconjugates.
Press OW
Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S19-26. PubMed ID: 9672771
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma patients.
Coiffier B
Haematologica; 1999 Jun; 84 Suppl EHA-4():14-8. PubMed ID: 10907457
[No Abstract] [Full Text] [Related]
9. [Monoclonal antibodies in therapy of malignant lymphomas].
Buske C; Engert A; Schnell R; Diehl V; Hiddemann W
Internist (Berl); 1998 Dec; 39(12):1205-14. PubMed ID: 10198827
[No Abstract] [Full Text] [Related]
10. Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma.
Collins-Burow B; Santos ES
Expert Rev Anticancer Ther; 2007 Mar; 7(3):257-73. PubMed ID: 17338647
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies in advanced B-cell lymphomas.
Ujjani C; Cheson BD
Oncology (Williston Park); 2010 Feb; 24(2):156-66. PubMed ID: 20361466
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy for non-Hodgkin's lymphoma: monoclonal antibodies and vaccines.
Maloney DG
J Clin Oncol; 2005 Sep; 23(26):6421-8. PubMed ID: 16155029
[TBL] [Abstract][Full Text] [Related]
13. Radiolabeled antibody therapy of B-cell lymphomas.
Press OW
Semin Oncol; 1999 Oct; 26(5 Suppl 14):58-65. PubMed ID: 10561019
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment with Rituximab for relapsing immune thrombocytopenic purpura (ITP) associated with low-grade non-Hodgkin's lymphoma.
Shvidel L; Klepfish A; Berrebi A
Am J Hematol; 2001 Jul; 67(3):213-4. PubMed ID: 11391724
[No Abstract] [Full Text] [Related]
15. Newer monoclonal antibodies for hematological malignancies.
Castillo J; Winer E; Quesenberry P
Exp Hematol; 2008 Jul; 36(7):755-68. PubMed ID: 18565392
[TBL] [Abstract][Full Text] [Related]
16. New therapeutic approaches to non-Hodgkin's lymphomas.
Lambert JF; Elfenbein GJ
Med Health R I; 2003 Aug; 86(8):236-9. PubMed ID: 14582217
[No Abstract] [Full Text] [Related]
17. Harnessing the energy: development of radioimmunotherapy for patients with non-Hodgkin's lymphoma.
Gregory SA; Hohloch K; Gisselbrecht C; Tobinai K; Dreyling M
Oncologist; 2009; 14 Suppl 2():4-16. PubMed ID: 19819920
[TBL] [Abstract][Full Text] [Related]
18. Antibody-targeted therapy for low-grade lymphoma.
Vose JM
Semin Hematol; 1999 Oct; 36(4 Suppl 6):15-20. PubMed ID: 10530712
[TBL] [Abstract][Full Text] [Related]
19. Phase II clinical trial of bolus infusion anti-B4 blocked ricin immunoconjugate in patients with relapsed B-cell non-Hodgkin's lymphoma.
Multani PS; O'Day S; Nadler LM; Grossbard ML
Clin Cancer Res; 1998 Nov; 4(11):2599-604. PubMed ID: 9829722
[TBL] [Abstract][Full Text] [Related]
20. Optimizing the treatment of patients with rituximab-pretreated recurrent indolent non-Hodgkin lymphoma.
Leonard JP; Gregory SA; Maloney DG; Vose JM; Younes A; Zelenetz AD
Clin Adv Hematol Oncol; 2008 Jun; 6(6):437-45. PubMed ID: 18567989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
